LGALS3 and melanoma: While we did not observe a significant decrease in Gal-1-binding (Supplementary Fig. 7b, c), we did observe a significant decrease in both exogenous and endogenous Gal-3-binding to GCNT2/I-branched glycan expressing melanoma cells (Supplementary Fig. 7d–g).